Head and neck cancer in the elderly-current aspects

被引:0
作者
Hoeing, B. [1 ]
Lang, S. [1 ]
Stuschke, M. [2 ]
Hansen, S. [1 ]
机构
[1] Klin Hals, Nasen,Ohrenheilkunde,Universitatsklinikum Essen, Univers Duisburg, Hufelandstrasse 55, DE-45147 Essen, Germany
[2] Klin Pol Strahlentherapie, Universitatsklinikum Essen, Essen, Germany
关键词
Head and neck neoplasms; Aged; Multimorbidity; Geriatric assessment; Algorithms; SQUAMOUS-CELL CARCINOMA; RADIATION; SURGERY; CARE;
D O I
10.1007/s00106-019-00792-1
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background The treatment of head and neck cancer is dominated by surgery and radiochemotherapy, which is in part associated with high morbidity. In elderly patients, however, the otorhinolaryngologist often has to question the rationality of invasive treatment. Although the proportion of geriatric patients with head and neck tumors is increasing, the paucity of data means that there are few consistent standards and recommendations in the literature and guidelines. Objective The aim of this paper is to provide concrete clinical recommendations for geriatric patients with head and neck tumors based on a systematic literature search. Materials and methods A keyword-based literature search was performed to present the current level of evidence and provide a clinical algorithm. Results In addition to age, the pretreatment dispositional evaluation of geriatric patients should include psychosocial, functional, and medical (patient history) comorbidities. For pretreatment risk stratification, an algorithm was created on the basis of these data for individual evaluation of the patient's pretreatment risk. Conclusion Pretreatment risk stratification of geriatric patients with head and neck malignancies is of high relevance for the individual decision for or against invasive treatment, but the currently available evidence is limited. This paper is based on a systematic literature review and provides a clinical algorithm for otorhinolaryngologists and head and neck surgeons.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 50 条
  • [41] Current Treatment Options for Metastatic Head and Neck Cancer
    Price, Katharine A. R.
    Cohen, Ezra E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 35 - 46
  • [42] Immunotherapy of head and neck cancer. Current developments
    Schuler, P. J.
    Hoffmann, T. K.
    Gauler, T. C.
    Bergmann, C.
    Brandau, S.
    Lang, S.
    HNO, 2013, 61 (07) : 559 - 572
  • [43] Current status of systemic therapy in head and neck cancer
    Mittal, Abhenil
    Sharma, Atul
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (01) : 9 - 24
  • [44] Current chemotherapies for recurrent/metastatic head and neck cancer
    Molin, Yann
    Fayette, Jerome
    ANTI-CANCER DRUGS, 2011, 22 (07) : 621 - 625
  • [45] Current status of experimental therapeutics for head and neck cancer
    Lee, Juna
    Moon, Chulso
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (04) : 375 - 389
  • [46] Head and neck cancer: Current challenges and future perspectives
    Bhat, Gh. Rasool
    Hyole, Rosalie G.
    Li, Jiong
    ADVANCES IN CANCER RESEARCH, VOL 152, 2021, 152 : 67 - 102
  • [47] Squamous cell carcinoma of the head and neck in the elderly
    Gugic, Jasenka
    Strojan, Primoz
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (01) : 16 - 25
  • [48] Current status and perspectives of brachytherapy for head and neck cancer
    Shibuya, Hitoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (01) : 2 - 6
  • [49] Current concepts of organ preservation in head and neck cancer
    Wang, C. -J.
    Knecht, R.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2011, 268 (04) : 481 - 487
  • [50] Current immuno-oncology in head and neck cancer
    Burian, Martin
    Neuchrist, Csilla
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (1-2) : 31 - 34